You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 12, December 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  THE PEDIATRIC FORUM
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

High-Dose Intravenous Methylprednisolone for Childhood Idiopathic Thrombocytopenic Purpura

SINASI ÖZSOYLU, MD
Department of Pediatrics and Hematology Unit Hacettepe University Faculty of Medicine and Hacettepe Children's Hospital 06100 Ankara, Turkey

Am J Dis Child. 1988;142(12):1273.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—I have read with interest Halperin and Doyle's article1 and Corrigan's editorial2 about bone marrow examination in idiopathic thrombocytopenic purpura (ITP). I would like to add a few points.

Formula

The authors do not mention that bone marrow examination also excludes megaloblastic anemia, which rarely presents with thrombocytopenia.

Corrigan2 states that "there is no laboratory test that is diagnostic of ITP in children." I believe that antiplatelet antibody determination by the modified Handin and Stossel method3 would serve this purpose. So far, antibodies have been determined in 177 acute cases (90 in the thrombocytopenic phase, 87 in remission, and 54 cases in both conditions) and in 55 chronic cases (35 in the thrombocytopenic period, 20 in remission, and eight cases in both conditions) of ITP. It was also studied in 126 controls (67 patients without hematologic disorders and 59 thrombocytopenic controls: 28 patients with leukemia, ten with aplastic anemia, ten with . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.